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Middle ear cholesteatoma is an important and relatively common disorder which may have 
serious consequences.
Aim: The purpose was to conduct a retrospective study of the statistics of 1,146 middle ear surgical 
procedures for middle ear cholesteatoma in adults and children of low income living in distant areas 
from our city.
Methods: From 1962 to 1988 there were 1,146 surgeries for unilateral or bilateral cholesteatomas in 
children and adults, which were reviewed for the following criteria: total number of surgeries, sex, 
onset of the first symptoms, duration of the disease, the site of perforation, the cholesteatoma site, 
changes in the ossicular chain, the contralateral ear, bilateral cholesteatomas, the site of residual 
cholesteatoma, and complications.
Results: Results are shown graphically on a pie chart.
Conclusion: The etiology of cholesteatomas remains unknown. Epidemiological and statistical data, 
surgical reports, and conclusions of experimental studies are welcome, as they may provide support 
for clarifying the pathogenesis of cholesteatoma. Our results were compared with internationally 
published papers. We found no published papers on the epidemiology of cholesteatoma in the 
Brazilian literature.
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INTRODUCTION/OBJECTIVE
The middle ear cholesteatoma is one of the most 
fascinating and complex topics in otology when studying 
its various aspects in depth. This topic has stimulated much 
research and debates worldwide.
It is an important and relatively common disease that 
may have serious consequences. Sade et al.¹ have shown 
that 0.5% to 30% of any given community has chronic 
otitis media; it is estimated that over 20 million people 
worldwide are affected. Of these, one fourth (about 5 
million) have cholesteatomas. The severity of this disease 
is a consequence of its effects, namely compression and 
infection. With time, it destroys the ear, resulting in hearing 
loss or deafness in most patients with this condition. At 
times, there may be a risk against their life.
This disease has been studied since ancient times; 
it was widely treated, although its detailed causes were 
poorly known. The name is controversial. The literal 
transcription comes from two Greek words: chole (bile) 
and steatoma (fatty tumor). Its location in the middle 
ear differentiates it from crystalline pearl tumors that are 
generally found in the endocranium. In its preferred site 
(the middle ear or the temporal bone), cholesteatomas are 
epidermoid structures with corneal degeneration.
The main factors that contribute to the development 
and frequency of cholesteatomas are: geography, genetics, 
sex, age, the environment, the social and economic status, 
health, incorrect use of antibiotics, and others.
Statistical epidemiologic studies may be used, but 
they are rather limited. There are reports that one or two 
Eskimos have chronic otitis media, but that the incidence 
of cholesteatoma is very low. Among the Canadian popu-
lation, its incidence is high in whites and low in blacks. It 
appears that genetic, anatomic, and physiological changes, 
added to geographical or environmental factors, affect the 
incidence of this disease. There appears to be no significant 
gender difference. Except for the congenital cholesteato-
ma, the incidence of this disease is higher in the elderly.
The incidence of cholesteatomas in childhood  and 
adolescence appears to depend on the environment, on 
social and economic factors, and on health.¹ It is related 
with secretory otitis in infancy, from before the advent of 
antibiotics, although this appears to have been neglected 
for a while. The level of healthcare in different countries 
appears also to affect the incidence of this condition.¹
Pediatricians and general practitioners often treat 
acute otitis, secretory otitis, and rhinopharyngeal diseases; 
these professionals at times do not evaluate these cases 
as required, and may prescribe antibiotics indiscriminate-
ly. It is well known that these conditions may foster the 
development of cholesteatoma.
This disease, as well as its subsequent effects on 
hearing, may become less frequent worldwide as pediatric 
otorhinolaryngology develops.¹
Except for histological studies of temporal bones, 
the epidemiology of cholesteatomas has been poorly 
studied in Brazil. As it is not a disease that has to be no-
tified, the true incidence of middle ear cholesteatoma is 
unknown in this country.
The purpose of this study was to carry out a retros-
pective evaluation of the statistics of 1,146 surgeries for 
middle ear cholesteatoma in adults and children from all 
regions in Brazil.
REVIEW OF THE LITERATURE
The incidence of cholesteatoma varies worldwide, 
depending on each population. Bezold2 has suggested 
that auditory canal dysfunction causes retraction of the 
tympanic membrane in cholesteatomas; the author re-
commended adenoidectomy as a preventive approach. 
Nager³ reviewed 12,000 patients with chronic middle ear 
discharge and found cholesteatomas in one third of cases. 
Tumarkin4 and Jain5 have suggested that economic factors 
may influence the pathogenesis of chronic otitis media, 
with reflexes on the epidemiology of cholesteatomas. 
Sade et al.6 studied the prevalence of cholesteatomas 
among ethnic groups at a hospital in Israel, showing that 
the ethnic distribution of bilateral perforation because of 
cholesteatomas differed significantly compared to other 
ear diseases. This difference is due to geogenes, rather 
than genes that have already been found. The annual rate 
of surgery for cholesteatoma has been estimated at 66 
per 100,000 inhabitants/year. Schuknecht7 has suggested 
that the epithelial pouch of cholesteatomas is dry; thus, 
keratin may accumulate slowly for years without causing 
complications; if an infection occurs, cholesteatomas 
may develop rapidly. Although not contributing to the 
pathogenesis of cholesteatomas or otitis media in climatic 
conditions, it may increase the frequency and severity of 
infection, accelerating the growth of a cholesteatoma and 
increasing disease severity. Harker8 reported an annual 
incidence of 6 cholesteatomas per 100,000 inhabitants/year 
in a population in Iowa, US; the incidence peaked in the 
second and third decades of life. Hatnesar9 has suggested 
that the prevalence is lower in Eskimos, suggesting that 
their anatomic and morphological features could facilitate 
aeration of the middle ear and thereby avoid the compli-
cations of chronic otites.
In the US, Ruben10 has shown that the incidence 
of cholesteatomas is 4.2 cases per 100,000 inhabitants/
year from 18 new chronic otitis media cases with or wi-
thout cholesteatomas. Tos¹¹ found an annual incidence of 
cholesteatomas of about 3 children and 12.6 adults per 
100,000 inhabitants/year in a study of 137 cholesteatomas 
in children and 603 cholesteatomas in adults, operated 
during a 16 year period. Van Cauwenberge et al.12 studied 
54 patients to investigate their clinical history of ear dise-
ases; acute recurring otitis media was the most important 
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disease. Middle ear effusions may predispose to chronic 
otitis media, of which cholesteatomas are a part. In the 
present study, the prevalence of cholesteatomas following 
tympanectomy was lower than 0.5%.
Manolidis et al.13 studied the epidemiology of 
cholesteatomas in Greece from 1960 to 1987 and found 
an equal frequency among patients of all social classes. 
Padgham et al.14 found an annual incidence of 13 choles-
teatomas per 100,000 inhabitants/year from 1966 to 1986 
in Scotland. Homoe & Bretlau15 found cholesteatomas in 
35 Greenlandic Inuit in 756 operations for chronic otitis 
media in Greenland from 1976 to 1991. The incidence was 
calculated at 5 cases per 100,000 inhabitants/year, about 
two new cases of cholesteatoma/year. Kempainen et al.16 
and Chinski17 have stated that cholesteatomas has a simi-
lar incidence among social groups; these authors showed 
that grommets placed in the ear reduce the prevalence 
of this disease. Nelson et al.18 divulged the incidence of 
cholesteatomas as being about 1.4 time higher in men 
compared to women. These authors reported that the mean 
age of children with congenital cholesteatoma was 5.6 
years; the mean age in children with the acquired disease 
was 9.7 years. Potsic et al.19 showed a high prevalence in 
Caucasian populations, followed by Afro-descendants in 
their epidemiological studies. Cholesteatomas were seen 
rarely in Asians. Olszenska et al.20 showed that the annu-
al incidence of cholesteatomas was about 3 per 100,000 
inhabitants/year in children, and about 9.2 per 100,000 
Caucasian adults/year, with a predominance in males. 
Dornelles et al.21 has monitored 450 Brazilian patients since 
August 2000, and has found a 30% rate of cholesteatoma-
tous chronic otitis media, which presented bilaterally in 
12% of the sample. Of these patients, 45% were aged not 
more than 18 years, therefore included in the pediatric 
and adolescent population; male patients comprised 70% 
of the cases.
METHODS
A longitudinal cohort retrospective survey was done 
of a statistical study of 1,146 cholesteatoma surgeries in 
adults and children from 1962 to 1988. For this study we 
selected cholesteatoma cases among about 5,000 files of 
patients treated medically and surgically for middle ear 
conditions. The series comprised 1,146 cases of choleste-
atoma surgeries in adults, adolescents, and children from 
all regions of Brazil.
The follow-up files of all patients were complete, 
containing the medical history, otoscopic and microscopic 
examination of the ear, nose, throat, and the pharyngeal 
ostium of the auditory tube, cultures and antibiograms of 
ear secretions, audiology and radiologic studies.
Epidemiologic data for several aspects of choleste-
atomas were studies, as follows:
1) number of procedures
2) sex
3) age of onset of the first symptom
4) the first symptom of the disease
5) duration of disease
6) perforation site
7) location
8) changes in the ossicular chain
9) the contralateral ear
10) bilateral cholesteatomas
11) the site of residual cholesteatomas.
RESULTS
The results of parameters are shown as graphs and 
pie charts.22 (Charts 1 to 11)
Chart 1. Total number of procedures.
Chart 2. Sex.
DISCUSSION
This study comprised 1,146 cases, of which 960 
were adults and 186 were children. Each group was 
considered in separate. There were 639 male (66.6%) 
and 321 female (33.4%) adult subjects. The age of adults 
ranged from 16 to 68 years; the age of children ranged 
from 4 to 15 years. Patients aged 16 complete years were 
considered as adults.
Males predominated slightly (64.7%) compared to 
females (35.3%) among both adults and children. Sadé 
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Chart 3. Age.
Chart 4. Age at onset of the first symptom (adults and children).
Chart 5. The first symptoms (adults and children).
Chart 6. Perforation site (adults and children).
Chart 7. Changes in the ossicular chain (adults and children).
Chart 8. The contralateral ear (adults and children).
Chart 9. Percentage of bilateral cholesteatomas (adults and children).
Chart 10. Site of residual cholesteatomas in the open technique (adults 
and children).
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et al.¹ found a male predominance (55.7%) over females 
(44.3%) for this disease.
The age at which patients present when choleste-
atomas are diagnosed was controversial because of the 
low social and economic status of patients in our series; 
the disease was found in 45.5% of our adult patients. We 
calculated that the onset of symptoms in about half of 
patients took place before 15 years of age, suggesting that 
childhood is important in this disease.
The duration of the disease from the onset of 
symptoms varies significantly among patients. About 30% 
of these patients wait from 6 to 15 years before seeking 
medical help; they carry the symptoms for years without 
a diagnosis.
We believe that two important factors cause such 
delays in the diagnosis:
a) patients often attribute little importance to oto-
logical symptoms except when there is pain, dizziness, 
or bleeding;
b) cholesteatomas may be well known to ENT 
specialists, but is less familiar to pediatricians and general 
practitioners.
The first and most frequent symptom of choles-
teatomas in our sample was otorrhea (66.5%), followed 
by combined otorrhea-hypoacusis-tinnitus (23.3%), and 
hypoacusis (7.6%).
Sadé et al.¹ found that a discharge was the first 
symptom in 62.0% of cases; hypoacusis was present in 
11.0% of cases.
We know that the perforation site on the tympanic 
membrane is rarely central; this occurred in 13.3% of our 
sample. Perforation was marginal and attical in 73.6% of 
cases. Sadé et al.¹ found marginal and attical perforation 
in 84.0% of their cases.
Cholesteatoma may be located in any of its possible 
sites, although the attic was involved more frequently.
The ossicular chain is the first structure to be dama-
ged. Two points should be made: we have never seen a 
damaged stirrup alone; and the most commonly damaged 
ossicle is the anvil. Palomar et al.23 has shown that the 
anvil was involved in 100% of ears where the ossicular 
chain was damaged.
The presence of middle ear cholesteatomas in 
patients with chronic otitis media results in a higher 
morbidity and mortality because of the erosion power 
of these epithelial growths (Sadé & Halevy24). Choleste-
atomas usually affect the ossicular chain; less frequently, 
they may also involve cranial bones, including the hardest 
bone of the body, the optic capsule, which demonstra-
tes its destructive power over bone. Partial or complete 
destruction of ossicles may be seen in 80% of patients 
with cholesteatomas. The ossicular chain erosion rate in 
chronic non-cholesteatomatous otitis media is about 20% 
(Chole25). The mechanisms by which bone is degraded in 
the presence of cholesteatomas remain unclear.
Swartz26 has suggested that destruction of ossicles 
is the most common complication of cholesteatomas; 
the type of destruction depends on the original site and 
expansion of the cholesteatoma. These authors found 
that the ossicular chain was intact in only 26% of attical 
cholesteatomas; the long process of the anvil was the most 
affected area, followed by the body of the anvil and the 
head of the hammer. Cholesteatomas in the portion under 
tension have a 90% erosion rate.
Several factors stimulate bone resorption, such as 
inflammation, local pressure, and specific cytokeratins 
(Olszewska et al.20). Abramson & Huang27 proposed the en-
zyme concept, in which epithelial enzymes are thought to 
cause bone destruction; these authors found collagenases 
and hydrolases in cholesteatomas. Thompsen28 and Ferlito 
et al.29 later confirmed this hypothesis by suggesting that 
collagenases produced by the components of fibrous and 
squamous epithelial tissues caused bone erosion. Other 
agents have since been added to the hypothesis of bio-
chemical bone resorption by collagenolytic enzymes only; 
these include the tumor necrosis factor (TNF), interleukins 
(IL-1a), and prostaglandins (PGE2) (Hansen et al.30).
Bone resorption mechanisms in chronic otitis me-
dia are not yet fully understood. Ruedi31 and Tumarkin32 
have suggested that bone resorption could occur as a 
result of pressure by cholesteatomas over ossicular sur-
faces. Thompsen et al.33 and Sadé & Berco34 found that 
inflammation invariably surrounded eroded ossicles, and 
suggested that inflammation could be the cause of ossicle 
resorption. Granulation tissue next to ossicles may produce 
several enzymes and mediators that may accelerate ossicle 
resorption; these include lysosomal enzymes, collagenases, 
and prostaglandins. The main cell that dominates the bone 
resorption process still is controversial. These authors have 
suggested that persisting inflammation in cholesteatoma-
tous chronic otitis media could give rise to a perpetual scar-
ring process in the perimatrix of cholesteatomas, thereby 
raising the level of cytokines. These, among other factors, 
could be accounted for the growth of cholesteatoma and 
the resulting bone destruction (Milewski35).
Ossicle alterations are part of the concept of chronic 
Chart 11. Location (adults and children).
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otitis media itself - irreversible inflammatory damage of 
tissues. The clinical effect is clear, as the conduction of 
sound to the inner ear is affected, resulting in conduction 
dysacusis of variable intensity. It is thought that chronic 
inflammatory changes in the ossicular chain follow a 
continuous and repetitive pattern. This means that the 
structure of ossicle is maintained in a fragile balance be-
tween its resistance and destructive mechanisms due to 
chronic inflammation.
The anvil was the most affected ossicle, followed 
by the hammer and the anvil. This is probably due to 
the incudal mass of the anvil, its prominent medulla, and 
especially the exposure and frailty of the long apophysis 
and its lenticular process. These factors acting synergisti-
cally appear to make this ossicle more vulnerable to ex-
trinsic damage and to osteomyelitis. These findings have 
confirmed those of Tos36 in a review of ossicle disease in 
1,150 ears with chronic otitis media; the anvil, stirrup, and 
hammer were shown to be more frequently affected by 
inflammation in that order.
It is currently thought that ossicle defects result from 
active bone resorption processes, rather than necrosis. This 
theory assumes that live cells participate in the mechanisms 
of bone demineralization, erosion, and destruction (Kranc 
et al.37). A necrotic bone may remain in place for years 
without being resorbed. This has been well illustrated in 
reconstructions of ossicle chains with homologous bone 
implants; in such cases, the ossicles remain intact in the 
long term, making it possible for sound to propagate 
through the middle ear.
Abramson38 and Deguine & Deguine39 have shown 
that the percentage of affected contralateral ears is about 
50% in cholesteatoma cases.
Deguine & Deguine39 found normal contralateral 
tympani in one third of their cases only; cholesteatomas 
were present in 10% of contralateral ears. Aquino40 found 
bilateral cholesteatomas in 19.6% of cases; the contralateral 
ear was normal in 47.6% of cases.
Abramson38 and Deguine & Deguine39 have found 
that cholesteatomas are bilateral in children in more than 
10% of cases; for Sheehy et al.,41 this rate is 8.0%.
The site of residual cholesteatomas in closed te-
chniques are, according to Aquino,40 40.0% in the attic, 
36.0% in the mesotympanic area, and 23.0% in other sites, 
confirming Wayoff et al’s.42 results.
CONCLUSION
Based on a survey of 1,146 cholesteatoma surgery 
cases we attempted to add knowledge about the epide-
miology of this condition in the Brazilian context, given 
that published papers on this specific topic are rare.
We hope this study will be added to other Brazilian 
studies to understand the true situation of cholesteatomas 
in our country.
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